AI assistant
Sending…
PALISADE BIO, INC. — Director's Dealing 2015
Apr 20, 2015
35274_dirs_2015-04-20_9cd2e46e-ba4b-41b9-a36e-f6c3f8ae62e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2015-04-17
Reporting Person: JOHE KARL (Director, Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-17 | Common Stock | G | 6800 | — | Disposed | 488947 | Direct |
Footnotes
F1: Disclosing a bonafde gift of 6,800 common shares by Reporting Person.
More from PALISADE BIO, INC.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 11